COVID-19 Vaccines Update

Oct 2, 2020Podcast0 comments

As phase 3 trials come to an end for front runners Pfizer and Moderna, the companies may be seeking emergency use authorization from the FDA in about a month. Widespread availability of vaccines for the general public would not be expected until near mid-2021.

Send in a voice message:


Submit a Comment

Your email address will not be published. Required fields are marked *